BRIEF SUMMARYCurrent Knowledge/Study Rationale: The aim of our study was to assess the effi ciency of fi brinolysis and its determinants, in particular thrombin activatable fi brinolysis inhibitor (TAFI), in OSA patients, since until now plasminogen activator inhibitor-1 and D-dimer have been the only fi brinolytic parameters studied in this disease. This is the fi rst study to investigate the effects of mandibular advancement splints on hemostasis in OSA patients. Study Impact: The study demonstrates antifi brinolytic mechanisms in OSA patients, largely mediated by increased TAFI. MAS treatment in OSA patients is associated with favorable alterations in hemostasis, including improved fi brinolysis.